APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory Therapeutics

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Selected research

Market Analysis & Forecast

Global Anti-inflammatory Therapeutics Market Analysis and Forecast 2026-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchAnti-inflammatory Therapeutics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory Therapeutics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory Therapeutics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.

Report Includes

Read the full market overview

This report presents an overview of global market for Anti-inflammatory Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-inflammatory Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-inflammatory Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-inflammatory Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-inflammatory Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anti-inflammatory Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Anti-inflammatory Therapeutics Segment by Company

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Anti-inflammatory Therapeutics Segment by Type

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

Anti-inflammatory Therapeutics Segment by Application

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Anti-inflammatory Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anti-inflammatory Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Anti-inflammatory Biologics Major Player Table 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Major Player Table 4. Corticosteroids Major Player Table 5. Others Major Player Table 6. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Arthritis Major Player Table 8. Respiratory Diseases Major Player Table 9. Dermatology Major Player Table 10. Gastroenterology Major Player Table 11. Others Major Player Table 12. Anti-inflammatory Therapeutics Industry Trends Table 13. Anti-inflammatory Therapeutics Industry Drivers Table 14. Anti-inflammatory Therapeutics Industry Opportunities and Challenges Table 15. Anti-inflammatory Therapeutics Industry Restraints Table 16. Global Anti-inflammatory Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Anti-inflammatory Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Anti-inflammatory Therapeutics Market Share by Region (2021-2026) Table 19. Global Anti-inflammatory Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Anti-inflammatory Therapeutics Market Share by Region (2027-2032) Table 21. Global Anti-inflammatory Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2021-2026) Table 23. Global Anti-inflammatory Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Anti-inflammatory Therapeutics Key Players Headquarters & Area Served Table 25. Global Anti-inflammatory Therapeutics Players, Product Type & Application Table 26. Global Anti-inflammatory Therapeutics Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Anti-inflammatory Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Anti-inflammatory Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2026) Table 33. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2027-2032) Table 34. Global Anti-inflammatory Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021-2026) Table 38. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2027-2032) Table 39. AbbVie Company Information Table 40. AbbVie Business Overview Table 41. AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. AbbVie Anti-inflammatory Therapeutics Product Portfolio Table 43. AbbVie Recent Development Table 44. Johnson & Johnson Company Information Table 45. Johnson & Johnson Business Overview Table 46. Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio Table 48. Johnson & Johnson Recent Development Table 49. Amgen Inc Company Information Table 50. Amgen Inc Business Overview Table 51. Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Amgen Inc Anti-inflammatory Therapeutics Product Portfolio Table 53. Amgen Inc Recent Development Table 54. AstraZeneca PLC Company Information Table 55. AstraZeneca PLC Business Overview Table 56. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio Table 58. AstraZeneca PLC Recent Development Table 59. Pfizer, Inc Company Information Table 60. Pfizer, Inc Business Overview Table 61. Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio Table 63. Pfizer, Inc Recent Development Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Novartis Anti-inflammatory Therapeutics Product Portfolio Table 68. Novartis Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Roche Anti-inflammatory Therapeutics Product Portfolio Table 73. Roche Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Merck Anti-inflammatory Therapeutics Product Portfolio Table 78. Merck Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Sanofi Anti-inflammatory Therapeutics Product Portfolio Table 83. Sanofi Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Sun Pharmaceutical Industries Ltd Company Information Table 90. Sun Pharmaceutical Industries Ltd Business Overview Table 91. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 92. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio Table 93. Sun Pharmaceutical Industries Ltd Recent Development Table 94. TEVA Company Information Table 95. TEVA Business Overview Table 96. TEVA Anti-inflammatory Therapeutics Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 97. TEVA Anti-inflammatory Therapeutics Product Portfolio Table 98. TEVA Recent Development Table 99. North America Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Anti-inflammatory Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Anti-inflammatory Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 113. China Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 114. China Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 115. China Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 116. China Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Anti-inflammatory Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Anti-inflammatory Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Anti-inflammatory Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Anti-inflammatory Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Anti-inflammatory Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Anti-inflammatory Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Anti-inflammatory Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Anti-inflammatory Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Anti-inflammatory Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Anti-inflammatory Therapeutics Image Figure 2. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Anti-inflammatory Biologics Image Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Image Figure 6. Corticosteroids Image Figure 7. Others Image Figure 8. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Anti-inflammatory Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Arthritis Image Figure 11. Respiratory Diseases Image Figure 12. Dermatology Image Figure 13. Gastroenterology Image Figure 14. Others Image Figure 15. Global Anti-inflammatory Therapeutics Market Size (US$ Million) & (2021-2032) Figure 16. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Anti-inflammatory Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Anti-inflammatory Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Anti-inflammatory Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Anti-inflammatory Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2032) Figure 23. Global Anti-inflammatory Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021-2032) Figure 26. North America Anti-inflammatory Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032) Figure 28. North America Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032) Figure 29. North America Anti-inflammatory Therapeutics Revenue Share by Country (2021-2032) Figure 30. United States Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Anti-inflammatory Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032) Figure 35. Europe Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032) Figure 36. Europe Anti-inflammatory Therapeutics Revenue Share by Country (2021-2032) Figure 37. Germany Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Anti-inflammatory Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032) Figure 47. China Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Anti-inflammatory Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032) Figure 50. Asia Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032) Figure 51. Asia Anti-inflammatory Therapeutics Revenue Share by Region (2021-2032) Figure 52. Japan Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Anti-inflammatory Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032) Figure 60. SAMEA Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032) Figure 61. SAMEA Anti-inflammatory Therapeutics Revenue Share by Country (2021-2032) Figure 62. Brazil Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Anti-inflammatory Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Others
Applications
  • Arthritis
  • Respiratory Diseases
  • Dermatology
  • Gastroenterology
  • Others
Companies covered
  • AbbVie
  • Johnson & Johnson
  • Amgen Inc
  • AstraZeneca PLC
  • Pfizer, Inc
  • Novartis
  • Roche
  • Merck
  • Sanofi
  • GlaxoSmithKline
  • Sun Pharmaceutical Industries Ltd
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-inflammatory Therapeutics Market by Type
  3. 1.2.1 Global Anti-inflammatory Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-inflammatory Biologics
  5. 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6. 1.2.4 Corticosteroids
  7. 1.2.5 Others
  8. 1.3 Anti-inflammatory Therapeutics Market by Application
  9. 1.3.1 Global Anti-inflammatory Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Arthritis
  11. 1.3.3 Respiratory Diseases
  12. 1.3.4 Dermatology
  13. 1.3.5 Gastroenterology
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Anti-inflammatory Therapeutics Market Dynamics
  1. 2.1 Anti-inflammatory Therapeutics Industry Trends
  2. 2.2 Anti-inflammatory Therapeutics Industry Drivers
  3. 2.3 Anti-inflammatory Therapeutics Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anti-inflammatory Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
  3. 3.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-inflammatory Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Anti-inflammatory Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anti-inflammatory Therapeutics Revenue by Players
  2. 4.1.1 Global Anti-inflammatory Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anti-inflammatory Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-inflammatory Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anti-inflammatory Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Anti-inflammatory Therapeutics Players, Product Type & Application
  8. 4.5 Global Anti-inflammatory Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anti-inflammatory Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Anti-inflammatory Therapeutics Tier 1, Tier 2, and Tier 3
5 Anti-inflammatory Therapeutics Market Size by Type
  1. 5.1 Global Anti-inflammatory Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2032)
6 Anti-inflammatory Therapeutics Market Size by Application
  1. 6.1 Global Anti-inflammatory Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AbbVie
  2. 7.1.1 AbbVie Company Information
  3. 7.1.2 AbbVie Business Overview
  4. 7.1.3 AbbVie Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Anti-inflammatory Therapeutics Product Portfolio
  6. 7.1.5 AbbVie Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Amgen Inc
  14. 7.3.1 Amgen Inc Company Information
  15. 7.3.2 Amgen Inc Business Overview
  16. 7.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
  18. 7.3.5 Amgen Inc Recent Developments
  19. 7.4 AstraZeneca PLC
  20. 7.4.1 AstraZeneca PLC Company Information
  21. 7.4.2 AstraZeneca PLC Business Overview
  22. 7.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
  24. 7.4.5 AstraZeneca PLC Recent Developments
  25. 7.5 Pfizer, Inc
  26. 7.5.1 Pfizer, Inc Company Information
  27. 7.5.2 Pfizer, Inc Business Overview
  28. 7.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
  30. 7.5.5 Pfizer, Inc Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novartis Anti-inflammatory Therapeutics Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Anti-inflammatory Therapeutics Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Merck
  44. 7.8.1 Merck Company Information
  45. 7.8.2 Merck Business Overview
  46. 7.8.3 Merck Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck Anti-inflammatory Therapeutics Product Portfolio
  48. 7.8.5 Merck Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Anti-inflammatory Therapeutics Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Sun Pharmaceutical Industries Ltd
  62. 7.11.1 Sun Pharmaceutical Industries Ltd Company Information
  63. 7.11.2 Sun Pharmaceutical Industries Ltd Business Overview
  64. 7.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
  66. 7.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
  67. 7.12 TEVA
  68. 7.12.1 TEVA Company Information
  69. 7.12.2 TEVA Business Overview
  70. 7.12.3 TEVA Anti-inflammatory Therapeutics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TEVA Anti-inflammatory Therapeutics Product Portfolio
  72. 7.12.5 TEVA Recent Developments
8 North America
  1. 8.1 North America Anti-inflammatory Therapeutics Revenue (2021-2032)
  2. 8.2 North America Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Anti-inflammatory Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Anti-inflammatory Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Anti-inflammatory Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Anti-inflammatory Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Anti-inflammatory Therapeutics Revenue by Country
  11. 8.6.1 North America Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anti-inflammatory Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Anti-inflammatory Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Anti-inflammatory Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anti-inflammatory Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anti-inflammatory Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anti-inflammatory Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anti-inflammatory Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anti-inflammatory Therapeutics Revenue by Country
  11. 9.6.1 Europe Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anti-inflammatory Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anti-inflammatory Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Anti-inflammatory Therapeutics Revenue (2021-2032)
  2. 10.2 China Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Anti-inflammatory Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Anti-inflammatory Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Anti-inflammatory Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Anti-inflammatory Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-inflammatory Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anti-inflammatory Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anti-inflammatory Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anti-inflammatory Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anti-inflammatory Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anti-inflammatory Therapeutics Revenue by Country
  11. 11.6.1 Asia Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anti-inflammatory Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anti-inflammatory Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-inflammatory Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Anti-inflammatory Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anti-inflammatory Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anti-inflammatory Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anti-inflammatory Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anti-inflammatory Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anti-inflammatory Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anti-inflammatory Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anti-inflammatory Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anti-inflammatory Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Anti-inflammatory Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anti-inflammatory Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anti-inflammatory Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst